Orthofix Medical Inc. $OFIX Stock Holdings Decreased by Great Lakes Advisors LLC

Key Points

• Great Lakes Advisors LLC reduced its stake in Orthofix Medical Inc. by 13.8%, selling 31,723 shares and maintaining about 0.51% ownership valued at $3.22 million.
• Orthofix Medical reported a quarterly loss of ($0.36) EPS, missing analysts' estimates, despite achieving revenue of $203.12 million for the quarter.
• The company's stock has shown recent volatility, with a current P/E ratio of -4.50, and shares trading down 2.5% at $14.25.

Great Lakes Advisors LLC trimmed its stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 13.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 197,551 shares of the medical device company's stock after selling 31,723 shares during the period. Great Lakes Advisors LLC owned about 0.51% of Orthofix Medical worth $3,222,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Engine Capital Management LP increased its stake in shares of Orthofix Medical by 8.4% during the 1st quarter. Engine Capital Management LP now owns 3,741,390 shares of the medical device company's stock worth $61,022,000 after purchasing an additional 290,646 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Orthofix Medical by 2.6% during the 1st quarter. Vanguard Group Inc. now owns 2,181,313 shares of the medical device company's stock worth $35,577,000 after purchasing an additional 54,528 shares in the last quarter. Juniper Investment Company LLC increased its stake in shares of Orthofix Medical by 10.3% during the 1st quarter. Juniper Investment Company LLC now owns 2,137,374 shares of the medical device company's stock worth $34,861,000 after purchasing an additional 200,125 shares in the last quarter. Soleus Capital Management L.P. increased its stake in shares of Orthofix Medical by 13.1% during the 4th quarter. Soleus Capital Management L.P. now owns 686,374 shares of the medical device company's stock worth $11,984,000 after purchasing an additional 79,441 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust increased its stake in shares of Orthofix Medical by 2.1% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 514,524 shares of the medical device company's stock worth $8,392,000 after purchasing an additional 10,722 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Orthofix Medical news, insider Aviva Mcpherron sold 3,728 shares of the business's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total value of $39,181.28. Following the transaction, the insider owned 46,322 shares in the company, valued at $486,844.22. The trade was a 7.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Orthofix Medical Stock Up 0.6%

Shares of NASDAQ:OFIX traded up $0.09 during midday trading on Tuesday, hitting $14.84. 29,048 shares of the company's stock traded hands, compared to its average volume of 338,018. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.67. The company has a market cap of $586.09 million, a PE ratio of -4.70 and a beta of 0.86. The firm's fifty day moving average price is $12.98 and its two-hundred day moving average price is $13.19. Orthofix Medical Inc. has a twelve month low of $10.24 and a twelve month high of $20.73.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The medical device company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.40). Orthofix Medical had a negative return on equity of 25.43% and a negative net margin of 15.29%.The firm had revenue of $203.12 million during the quarter, compared to analyst estimates of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Orthofix Medical Inc. will post -2.81 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Orthofix Medical from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research raised shares of Orthofix Medical to a "strong-buy" rating and set a $16.00 price objective for the company in a research note on Monday, June 23rd. Finally, JMP Securities reissued a "market perform" rating on shares of Orthofix Medical in a research note on Friday, June 6th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $21.50.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.